The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
- PMID: 1652369
- DOI: 10.1016/0092-8674(91)90113-d
The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
Abstract
We have previously shown that the t(15;17) translocation specifically associated with acute promyelocytic leukemia (APL) fuses the retinoic acid receptor alpha (RAR alpha) locus to an as yet unknown gene, initially called myl and now renamed PML. We report here that this gene product contains a novel zinc finger motif common to several DNA-binding proteins. The PML-RAR alpha mRNA encodes a predicted 106 kd chimeric protein containing most of the PML sequences fused to a large part of RAR alpha, including its DNA- and hormone-binding domains. In transient expression assays, the hybrid protein exhibits altered transactivating properties if compared with the wild-type RAR alpha progenitor. Identical PML-RAR alpha fusion points are found in several patients. These observations suggest that in APL, the t(15;17) translocation generates an RAR mutant that could contribute to leukemogenesis through interference with promyelocytic differentiation.
Similar articles
-
Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML.Cell. 1991 Aug 23;66(4):663-74. doi: 10.1016/0092-8674(91)90112-c. Cell. 1991. PMID: 1652368
-
Acute promyelocytic leukemia: from clinic to molecular biology.Stem Cells. 1995 Jan;13(1):22-31. doi: 10.1002/stem.5530130104. Stem Cells. 1995. PMID: 7719245 Review.
-
Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.Oncogene. 1995 Jun 15;10(12):2307-14. Oncogene. 1995. PMID: 7784078
-
The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.Oncogene. 1994 Feb;9(2):545-51. Oncogene. 1994. PMID: 8290265
-
The molecular genetics of acute promyelocytic leukemia.Blood Rev. 1993 Jun;7(2):87-93. doi: 10.1016/s0268-960x(05)80018-9. Blood Rev. 1993. PMID: 8396481 Review.
Cited by
-
Emerging Cellular Functions of Cytoplasmic PML.Front Oncol. 2013 Jun 6;3:147. doi: 10.3389/fonc.2013.00147. eCollection 2013. Front Oncol. 2013. PMID: 23761861 Free PMC article.
-
Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies.Int J Mol Sci. 2024 Feb 17;25(4):2369. doi: 10.3390/ijms25042369. Int J Mol Sci. 2024. PMID: 38397043 Free PMC article. Review.
-
Tumor suppressive pathways in the control of neurogenesis.Cell Mol Life Sci. 2013 Feb;70(4):581-97. doi: 10.1007/s00018-012-1063-9. Epub 2012 Jul 17. Cell Mol Life Sci. 2013. PMID: 22802124 Free PMC article. Review.
-
Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells.Cell Mol Biol Lett. 2012 Dec;17(4):501-25. doi: 10.2478/s11658-012-0024-5. Epub 2012 Jul 20. Cell Mol Biol Lett. 2012. PMID: 22820861 Free PMC article.
-
PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.Mol Cell Biol. 2007 Aug;27(16):5819-34. doi: 10.1128/MCB.02422-06. Epub 2007 Jun 11. Mol Cell Biol. 2007. PMID: 17562868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
